Fibrocystic Breast Disease clinical trials
The registry lists 11 studies for Fibrocystic Breast Disease across 6 countries. 1 are recruiting or about to start. 7 of them are mainly about Fibrocystic Breast Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.
Get an email when these change. Save the Fibrocystic Breast Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
FemmePharma Global Healthcare, Inc. (2) · Mayo Clinic (1) · Hadassah Medical Organization (1) · Catalysis SL (1) · University of Florida (1) · Medical College and Hospital Kolkata (1) · Washington University School of Medicine (1) · Symbollon Pharmaceuticals (1)
What is being tested here
Drugs under test in Fibrocystic Breast Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Danazol | 0 | 0 | 2 |
| Tamoxifen | 0 | 0 | 1 |
| Evening primrose oil | 0 | 0 | 1 |
| Green Tea Extract-based Antioxidant Supplement | 0 | 1 | 1 |
| Abemaciclib | 0 | 0 | 1 |
| Iodine | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Aug 2027A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials · University of Florida
Who these studies take
Of the 1 Fibrocystic Breast Disease studies recruiting now, 0 (0%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 11 studies, recruiting or not: 27% stop at 75 or younger and 27% at 65; 9% take children; 91% are for women only and 0% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 15, 2026.
Results posted1
Studies
Recruiting first, then most recently updated. Showing 11 of 11. search them.
- A Multilevel Approach to Connecting Underrepresented Populations to Clinical TrialsRecruitingNCT056554941 country
- Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast CancerTerminatedNCT03979508Phase 21 country
- Possibilities of Phytomedicine in Monotherapy of Benign Breast DiseasesCompletedNCT05717894Phase 41 country
- A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie CapsuleStatus unknownNCT02929420Phase 41 country
- A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast MassesCompletedNCT00826488Early Phase 11 country
- Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast CancerCompletedNCT00999921Phase 41 country
- Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic DiseaseCompletedNCT00967681Phase 31 country
- An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic MastalgiaCompletedNCT01105793Phase 21 country
- Involvement of Endogenous Digitalis-like Compounds in Breast CancerWithdrawnNCT003108821 country
- A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast DiseaseCompletedNCT00744276Phase 21 country
- Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast PainStatus unknownNCT00237523Phase 31 country